E3 ubiquitin ligase UBR5 promotes pancreatic cancer growth and aerobic glycolysis by downregulating FBP1 via destabilization of C/EBP[alpha]

• Published in: Oncogene Vol. 40; no. 2; p. 262
• Main Authors: Chen, Leifeng, Yuan, Rongfa, Wen, Chongyu, Liu, Tiande, Feng, Qian, Deng, Xueqiang, Du, Yunyan
• Format: Journal Article
• Language: English
• Published: Nature Publishing Group 14.01.2021
• Subjects: Care and treatment; Development and progression; Genetic aspects; Genetic regulation; Health aspects; Ligases; Pancreatic cancer; Phosphatases; China
• ISSN: 0950-9232; 1476-5594
• DOI: 10.1038/s41388-020-01527-1

Pancreatic cancer is one of the most fatal cancers in humans. While it thrives in a state of malnutrition, the mechanism by which pancreatic cancer cells adapt to metabolic stress through metabolic reprogramming remains unclear. Here, we showed that UBR5, an E3 ubiquitin ligase, was significantly upregulated in pancreatic cancer patient samples compared to the levels in adjacent normal tissues. Levels of UBR5 were closely related to a malignant phenotype and shorter survival among pancreatic cancer patients. Multivariate analyses also revealed that UBR5 overexpression was an independent predictor of poor outcomes among patients with pancreatic cancer. Functional assays revealed that UBR5 contributes to the growth of pancreatic cancer cells by inducing aerobic glycolysis. Furthermore, we demonstrated that UBR5 knockdown increased levels of fructose-1,6-bisphosphatase (FBP1), an important negative regulator in the process of aerobic glycolysis in many cancers. We found a significant negative correlation between levels of UBR5 and FBP1, further demonstrating that UBR5-induced aerobic glycolysis is dependent on FBP1 in pancreatic cancer cells. Mechanistically, UBR5 regulates FBP1 expression by modulating C/EBP[alpha], directly binding to C/EBP[alpha], and promoting its ubiquitination and degradation. Together, these results identify a mechanism used by pancreatic cancer cells to survive the nutrient-poor tumour microenvironment and also provide insight regarding the role of UBR5 in pancreatic cancer cell adaptation to metabolic stresses.